Background. Although fine-needle aspiration (FNA) is 90% sensitive in
the detection of papillary carcinoma (PC) of the thyroid, its specific
ity has been reported as low as 52%. Consequently, patients who have a
n FNA suspicious for PC may undergo operation for a benign process. Th
e ribonucleoprotein. telomerase has been noted to be activated in a wi
de variety of carcinomas. We examined 30 PCs for telomerase activity t
o determine whether this would be a useful adjunct to FNA in the diagn
osis of lesions suspicious for PC. Methods. Standard telomere repent a
mplification protocol assays were performed on fresh frozen tissue sam
ples from 30 PCs, 3 benign nodules, and 10 normal thyroids. Results. T
elomerase activity was documented in 20 of 30 (67%) of the PCs, 0 of 3
benign nodules, and 0 of 10 normal thyroids. In all, 11 of the 20 PCs
had FNA cytology that was nondiagnostic of PC, and 2 of the benign no
dules had FNA that was suspicious for PC. Conclusions. The telomerase
assay appears useful in the distinction of benign from malignant thyro
id lesions that have FNA suspicious for but not diagnostic of PC. On t
he basis of these findings, a prospective trial examining telomerase a
ctivity in FNAs suspicious for thyroid cancer has been initiated.